Discover how immune iFRET biomarkers offer new insights into predicting response to neoadjuvant melanoma therapy, driving ...

Daiichi Sankyo's stock dropped 25% due to disappointing clinical data, but upcoming studies could drive a rebound for ...

An international team of UK and US scientists discovered that the activity of macrophages -- a type of white blood cell that engulf pathogens and cancer cells -- can be used to predict whether or not ...

Incorporating genomic testing into the management of cervical cancer allows for the creation of personalized treatment plans ...

Background The immune suppression mechanisms in pancreatic ductal adenocarcinoma (PDAC) remain unknown, but preclinical ...

The melding of visual information (microscopic and X-ray images, CT and MRI scans, for example) with text (exam notes, communications between ...

An international team of UK and US scientists has discovered that the activity of macrophages—a type of white blood cell that ...

The FDA cleared the investigational new drug application for REC-4539, allowing for the start of a phase 1/2 trial in small ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Top-line Phase 2/3 data readout for CTX-009, now named tovecimig (a DLL4 x VEGF-A bispecific), in patients with biliary tract cancer (BTC) is on ...

Colorectal cancer (CRC) is the third most common cancer and the second most common cause of cancer deaths worldwide. In 2023, ...

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will ...